和铂医药-B11月17日斥资137.5万港元回购10万股
Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 100,000 shares at a total cost of HKD 1.375 million [1] - The buyback price per share ranges from HKD 13.68 to HKD 13.80 [1]